India allocates just 0.1 percent of GDP on publicly funded drugs and medicines — a catastrophe for the country's vast poor population, argues Sachi Satapathy, a technical officer at The International Union Against Tuberculosis and Lung Disease, in this guest column.
Sign in or join Devex to read the rest
Not only will you get to finish this article, you will also unlock access to community content from our global team of journalists covering the latest global health, humanitarian aid and international development news. And it's totally free.
